Francesco Peri
Prof., University of Milano-Bicocca
Full Professor (Organic and Medicinal Chemistry) at the Department of Biotechnology and Biosciences, of the University of Milano-Bicocca (Milano, Italy). He holds a permanent professorship at the Ecole Normale Supérieure (ENS) of Lyon (France) where he teaches a course of Medicinal Chemistry (Master level). In 2012, he had a permanent professorship in Organic Chemistry at the University Paris 5, and in 2012 he was for 1 year Visiting Professor at the Department of Chemistry, University of California, Davis (USA) giving graduate courses.
His research activity focuses on medicinal chemistry, bioorganic chemistry and drug development. New TLR4 modulators have been developed and patented by his group, as well as first-in-class drug leads against heart failure, that target the activity of the Serca2a protein.
He is author of more than 120 scientific publications, 10 patents, H index = 36 (March 2021, Google scholar).